- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 04-02-2026: Press Release
04-02-2026 | 02:38 pm
04-02-2026 | 02:38 pm
Zydus received USFDA tentative approval for Dapagliflozin Tablets, a diabetes medication. This drug market recorded annual US sales of approximately $1,048.69 Cr, signalling a significant opportunity for Zydus.
No comments yet. Be the first to comment!